MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway

The Journal of Gene Medicine
Guozhu LiuHao Zhang

Abstract

Triple-negative breast cancer (TNBC) has become a common tumor that harms women's physical and mental health, as characterized by a relatively rapid recurrence and a high incidence of brain metastasis. Research increasingly suggests that microRNAs play key roles in the progress of TNBC. However, the function of miR-6838-5p in TNBC has not yet been reported, and requires additional exploration. In the present study, we uncovered miR-6838-5p expression in TNBC cells via a quantitative reverse transcriptase-polymerase chain reaction. Functionally, the impacts of up-regulated or down-regulated miR-6838-5p on TNBC invasiveness, Wnt pathway activation and epithelial-mesenchymal transition (EMT) were investigated via transwell and western blot assays. Mechanical analyses were utilized to unmask the miR-6838-5p mechanism in TNBC, including luciferase reporter, western blot and RIP assays. Rescue assays manifested the miR-6838-5p/WNT3A network in TNBC invasiveness through the Wnt pathway. Under-expressed miR-6838-5p was found in TNBC cells. Up-regulation of miR-6838-5p suppressed TNBC cell invasion, migration and blockade of the Wnt pathway. However, down-regulation of miR-6838-5p led to opposite results. Furthermore, we found, via luci...Continue Reading

References

Sep 17, 2004·Nature·Victor Ambros
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
Nov 9, 2010·Molecular Diagnosis & Therapy·Maged Gomaa HemidaDecheng Yang
Nov 26, 2013·Methods in Molecular Biology·Kemal Uğur TüfekciSermin Genç
Sep 6, 2014·Current Pharmaceutical Biotechnology·Yusuf Tutar
Oct 6, 2016·Genetics and Molecular Research : GMR·X Z YinL Liu
Jun 10, 2017·Molecular Oncology·Meggy Suarez-CarmonaChristine Gilles
Aug 3, 2017·Expert Opinion on Therapeutic Targets·Mary Kathryn PitnerChandra Bartholomeusz
Oct 2, 2017·Pathology, Research and Practice·Tomasz PowrózekTeresa Małecka-Massalska
Mar 14, 2018·ACS Chemical Biology·Gayan Mirihana ArachchilageSoumitra Basu
May 8, 2018·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yue WuXiao Wang
Jun 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiangdong BaiQiang He
Jul 18, 2018·International Urology and Nephrology·Paweł PorzyckiMirosław Tyrka
Sep 15, 2018·Ginekologia polska·Sebastian NiedźwieckiArkadiusz Jeziorski

❮ Previous
Next ❯

Citations

Jul 17, 2020·Non-coding RNA·Jun Sheng Wong, Yoke Kqueen Cheah
Oct 22, 2020·International Journal of Molecular Sciences·Malvina KoniMaria Felice Brizzi
Jul 25, 2021·International Journal of Molecular Sciences·Fu PengXiaoqi Pan
Oct 7, 2021·Bioscience Reports·Ying Jing, Donghai Li
Dec 1, 2020·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Weidong ZhouPeifei Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.